Clinical Trial Update: Intravenous Silibinin in Combination With Peg-interferon and Ribavirin in Nonresponders [Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 2 trial evaluating intravenous silibinin in combination with pegylated interferon and ribavirin in hepatitis C p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Pegylated interferon alfa-2a (Peginterferon alfa-2a)
• Ribavirin (ribavirin)
• Silibinin (silibinin)

Snippet

Sponsor: Medical University of Vienna | Conditions: Hepatitis C | Phase 2 | Status: COMPLETED